A New European Consortium to Boost our Understanding of IBD
Thursday, May 23, 2013
A multi-modal integrated biomarker study Consortium to increase diagnostic precision in detection of the diseases.
Cenix BioScience and Debiopharm Sign Research Agreement
Thursday, May 23, 2013
Both Companies collaborate to identify predictive biomarkers.
Biomarkers Found for Major Depressive Disorder
Thursday, May 23, 2013
New research highlights biological and genetic markers associated with improved response to adjunctive L-Methylfolate in management of depression.
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientific Officer
Thursday, May 23, 2013
Dr. Olson’s extensive experience in personalized medicine will support Syros’ mission to lead in gene control.
Mayo Clinic Forms Joint Venture with Cancer Genetics
Thursday, May 23, 2013
OncoSpire Genomics will seek to discover and commercialize biomarkers for multiple cancer types.
Biomarkers Discovered for Inflammatory Bowel Disease
Thursday, May 23, 2013
Researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and intervention.
Ignyta Announces Acquisition of Actagene Oncology and Entry into Oncology Personalized Medicine
Tuesday, May 21, 2013
Company adds world class drug discovery and development veterans to management and advisory team.
Olink Bioscience Appoints Sigma-Aldrich as Distributor of Duolink
Friday, May 17, 2013
Olink Bioscience will continue to develop the protein biomarker market.
Your Immune System: On Surveillance in the War Against Cancer
Monday, May 13, 2013
Wake Forest Baptist Research looks at gene expression profiling in breast cancer.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 21 - 30 of 4179 |
|
|
